statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT - Free Report) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the stock...

StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT)

StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT  Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the...

DBV Technologies (NASDAQ:DBVT) Receives New Coverage from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT  Get Free Report) in a report issued on Monday. The firm set a hold rating on the...

StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT)

DBV Technologies (NASDAQ:DBVT  Get Free Report)s stock had its buy rating restated by stock analysts at HC Wainwright in a report released on Wednesday, Benzinga reports...

DBV Technologies (NASDAQ:DBVT) Rating Reiterated by HC Wainwright

Montrouge, France, February 20 2024 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress DBV Technologies (Euronext: DBV ISIN: FR0010417345 NASDAQ: DBVT), a clinical-stage...

DBV Technologies to Participate in Upcoming AAAAI 2024 Congress

DBV Technologies (NASDAQ:DBVT  Get Free Report) was downgraded by analysts at StockNews.com from a hold rating to a sell rating in a research note issued to...

DBV Technologies (NASDAQ:DBVT) Rating Lowered to Sell at StockNews.com

DBV Technologies S.A. (NASDAQ:DBVT  Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.87 and traded as high...

DBV Technologies (NASDAQ:DBVT) Share Price Crosses Above 50-Day Moving Average of $0.87

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.

Volume	28,964.00
52-Wk High	$2.37
52-Wk Low	$0.65

DBVT DBV Technologies

About

Feed

News

Sentiment

Earnings

Fundamentals